Alyeska Investment Group, L.P. - Apr 4, 2022 Form 3 Insider Report for MedAvail Holdings, Inc. (MDVL)

Role
10%+ Owner
Signature
Alyeska Investment Group, L.P., By: /s/ Jason Bragg, Chief Financial Officer
Stock symbol
MDVL
Transactions as of
Apr 4, 2022
Transactions value $
$0
Form type
3
Date filed
5/23/2022, 04:05 PM
Next filing
Oct 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MDVL Common Stock 7.54M Apr 4, 2022 Direct F1, F2, F3, F4
holding MDVL Common Stock 7.54M Apr 4, 2022 Direct F1, F2, F3, F4
holding MDVL Common Stock 7.54M Apr 4, 2022 Footnotes F1, F2, F3, F4
holding MDVL Common Stock 7.54M Apr 4, 2022 Footnotes F1, F2, F3, F4
holding MDVL Common Stock 7.54M Apr 4, 2022 Footnotes F1, F2, F3, F4
holding MDVL Common Stock 7.54M Apr 4, 2022 Footnotes F1, F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MDVL Warrants Apr 4, 2022 Common Stock 3.76M $1.25 Direct F1, F2, F3, F4
holding MDVL Warrants Apr 4, 2022 Common Stock 3.76M $1.25 Direct F1, F2, F3, F4
holding MDVL Warrants Apr 4, 2022 Common Stock 3.76M $1.25 Footnotes F1, F2, F3, F4
holding MDVL Warrants Apr 4, 2022 Common Stock 3.76M $1.25 Footnotes F1, F2, F3, F4
holding MDVL Warrants Apr 4, 2022 Common Stock 3.76M $1.25 Footnotes F1, F2, F3, F4
holding MDVL Warrants Apr 4, 2022 Common Stock 3.76M $1.25 Footnotes F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 7,539,411 shares of Common Stock, par value $0.001 per share ("Shares"), of MedAvail Holdings, Inc. and warrants to purchase 3,764,705 Shares ("Warrants"). The Warrants cannot be exercised if, after giving effect thereto, the Fund would beneficially own more than 9.99% of the total outstanding Shares of MedAvail Holdings, Inc. The Investment Manager receives an asset-based fee relating to the Shares and Warrants directly held by the Fund, and does not hold a pecuniary interest in such Shares or Warrants.
F2 (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund.
F3 The filing of this Form 3 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares or Warrants. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest.
F4 The Reporting Persons are jointly filing this Form 3 pursuant to Rule 16(a)-3(j) under the Exchange Act.